Disclosures for "Efficacy and Safety of Extended-release Carbidopa Levodopa (IPX203) versus Immediate-release Carbidopa Levodopa in the Management of Parkinson’s Disease: A Systematic Review "
-
Mr. Aljadani has nothing to disclose.
-
Mr. Barwais has nothing to disclose.
-
Author has nothing to disclose
-
Mr. Alharbi has nothing to disclose.
-
Mr. alharith has nothing to disclose.
-
Dr. Fallatah has nothing to disclose.
-
Mr. Halabi has nothing to disclose.
-
Dr. Hakami has nothing to disclose.